Basic Information
RNALocate ID: | RLID-D:11001449 |
RNA Symbol: | hsa-miR-16-1-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-16-1-3p |
RNA ID: | miRBase:MIMAT0004489 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003569 | Exosome | Plasma | 23663360 |
RLID-D:11000571 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-16-1-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-18530 |
MNDR | hsa-miR-16-1-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-18531 |
MNDR | hsa-miR-16-1-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-18532 |
MNDR | hsa-miR-16-1-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-18533 |
MNDR | hsa-miR-16-1-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-18534 |
MNDR | hsa-miR-16-1-3p | Her2-receptor positive breast cancer | MNDR-E-MI-18535 |
MNDR | hsa-miR-16-1-3p | Acute promyelocytic leukemia | MNDR-E-MI-18536 |
MNDR | hsa-miR-16-1-3p | Prostate cancer | MNDR-E-MI-18537 |
MNDR | hsa-miR-16-1-3p | Chronic lymphocytic leukemia | MNDR-E-MI-18538 |
MNDR | hsa-miR-16-1-3p | Gastric cancer | MNDR-E-MI-18539 |
MNDR | hsa-miR-16-1-3p | Esophageal carcinoma | MNDR-E-MI-18540 |
MNDR | hsa-miR-16-1-3p | Lung cancer | MNDR-E-MI-18541 |
MNDR | hsa-miR-16-1-3p | Parkinson disease | MNDR-E-MI-18542 |
MNDR | hsa-miR-16-1-3p | Breast cancer | MNDR-E-MI-18543 |
MNDR | hsa-miR-16-1-3p | Pituitary neoplasms | MNDR-E-MI-18544 |
MNDR | hsa-miR-16-1-3p | Pancreatic cancer | MNDR-E-MI-18545 |
MNDR | hsa-miR-16-1-3p | Nephroblastoma | MNDR-E-MI-18546 |
MNDR | hsa-miR-16-1-3p | Colon cancer | MNDR-E-MI-18547 |
MNDR | hsa-miR-16-1-3p | Familial ovarian cancer | MNDR-E-MI-18548 |
MNDR | hsa-miR-16-1-3p | Prostate adenocarcinoma | MNDR-E-MI-18549 |
MNDR | hsa-miR-16-1-3p | Carcinoma ductal breast | MNDR-E-MI-18550 |
MNDR | hsa-miR-16-1-3p | Glioblastoma | MNDR-E-MI-18551 |
MNDR | hsa-miR-16-1-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-18552 |
MNDR | hsa-miR-16-1-3p | Osteosarcoma | MNDR-E-MI-18553 |
MNDR | hsa-miR-16-1-3p | Breast carcinoma | MNDR-E-MI-18554 |
MNDR | hsa-miR-16-1-3p | Uterine cancer | MNDR-E-MI-18555 |
MNDR | hsa-miR-16-1-3p | Gastric adenocarcinoma | MNDR-E-MI-18556 |
MNDR | hsa-miR-16-1-3p | Cervical squamous cell carcinoma | MNDR-E-MI-18557 |
MNDR | hsa-miR-16-1-3p | Lung squamous cell carcinoma | MNDR-E-MI-18558 |
MNDR | hsa-miR-16-1-3p | Lung adenocarcinoma | MNDR-E-MI-18559 |
MNDR | hsa-miR-16-1-3p | Thyroid carcinoma | MNDR-E-MI-18560 |
MNDR | hsa-miR-16-1-3p | Bladder urothelial carcinoma | MNDR-E-MI-18561 |
MNDR | hsa-miR-16-1-3p | Pancreatic adenocarcinoma | MNDR-E-MI-18562 |
MNDR | hsa-miR-16-1-3p | Carcinoma renal cell | MNDR-E-MI-18563 |
MNDR | hsa-miR-16-1-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-18564 |
MNDR | hsa-miR-16-1-3p | Renal clear cell carcinoma | MNDR-E-MI-18565 |
MNDR | hsa-miR-16-1-3p | Cholangiocarcinoma | MNDR-E-MI-18566 |
MNDR | hsa-miR-16-1-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-18567 |
MNDR | hsa-miR-16-1-3p | Adenoma | MNDR-E-MI-18568 |
MNDR | hsa-miR-16-1-3p | Breast invasive carcinoma | MNDR-E-MI-18569 |
MNDR | hsa-miR-16-1-3p | Hepatocellular carcinoma | MNDR-E-MI-18570 |
MNDR | hsa-miR-16-1-3p | Familiar ovarian carcinoma | MNDR-E-MI-18571 |
MNDR | hsa-miR-16-1-3p | Malignant pleural mesothelioma | MNDR-E-MI-18572 |
MNDR | hsa-miR-16-1-3p | Chronic myeloid leukemia | MNDR-E-MI-18573 |
MNDR | hsa-miR-16-1-3p | Colorectal cancer | MNDR-E-MI-18574 |
MNDR | hsa-miR-16-1-3p | Prostatic neoplasms | MNDR-E-MI-18575 |
MNDR | hsa-miR-16-1-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-18576 |
MNDR | hsa-miR-16-1-3p | Breast cancer her3+ negative | MNDR-E-MI-18577 |
MNDR | hsa-miR-16-1-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-18578 |
MNDR | hsa-miR-16-1-3p | Tubulovillous adenoma | MNDR-E-MI-18579 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BCL2 | Homo sapiens | RR00218998 |
TOP